Background Current guidelines recommend screening of people with oesophageal varices
via oesophago‐gastro‐duodenoscopy at the time of diagnosis of hepatic cirrhosis. This …

In patients with compensated advanced chronic liver disease (cACLD), the presence of
clinically significant portal hypertension (CSPH) and varices needing treatment (VNT) bears …

Background Esophageal variceal bleeding remains the leading cause of acute mortality in
patients with cirrhosis. Platelet count to spleen diameter (PC/SD) ratio less than 909 is one …

METHODS A total of 218 cirrhotic patients underwent screening endoscopy for EV. Platelet
count/spleen diameter ratio ((N/mm 3)/mm) was assessed in all patients and its diagnostic …

Materials and Methods This was a cross sectional observational study. Child Turcot Pugh
scores, MELD, AST ALT Ratio (AAR), AST Platelet Ratio Index (APRI), FIB-4 index and …

Background Portal hypertension (PH), defined by hepatic venous pressure gradient
(HVPG)≥ 5 mmHg and clinically significant PH, defined by HVPG≥ 10 mmHg, are …

BACKGROUND & AIMS: The validation of noninvasive tests to diagnose esophageal varices
is a priority in children because repeated endoscopic evaluations are too invasive. We …

Methods: Fifty-one consecutive children with liver disease or portal hypertension who
underwent endoscopy were included in the present retrospective study. At endoscopy …

Background All patients with liver cirrhosis are recommended to undergo an evaluation of
esophageal varices (EV) to assess their risk of bleeding. Predicting the presence of EV …

Background & aims Platelet count/spleen longest diameter ratio (PSDR) is widely used in
clinical practice due to its good performance in predicting esophageal varices (EV). We …